For any queries, please contact Customer Services or your Account Manager. Dismiss
Antitrust - Mallinckrodt - KVK's legislation over alleged monopolization of FDFs (US)
Mallinckrodt has been accused in a US complaint of illegally monopolizing the market for the manufacture and sale of pain pills containing Oxycodone and the Acetaminophen USP by refusing to deal with KVK Tech in supplying Oxycodone and Acetaminophen USP active pharmaceutical ingredients without a legitimate business reason and despite doing business for several years.
To add details to this portfolio regarding legal or economic representatives, please contact editors@mlex.com.
Timeline
Parties
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
Already a subscriber? Click here to login